The economics of screening for microalbuminuria in patients with insulin-dependent diabetes mellitus

Pharmacoeconomics. 1994 May;5(5):357-60. doi: 10.2165/00019053-199405050-00001.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Albuminuria / diagnosis*
  • Albuminuria / epidemiology
  • Cost-Benefit Analysis
  • Diabetes Mellitus, Type 1 / complications*
  • Diabetic Neuropathies / drug therapy
  • Forecasting
  • Humans
  • Mass Screening / economics*
  • Mass Screening / methods
  • Mass Screening / trends
  • Risk Factors